1g5y › Citations

Structural basis for autorepression of retinoid X receptor by tetramer formation and the AF-2 helix.

Gampe RT, Montana VG, Lambert MH, Wisely GB, Milburn MV, Xu HE
Genes Dev 14 2229-41 (2000)
Cited: 86 times
EuropePMC logo PMID: 10970886

Abstract

The 9-cis-retinoic acid receptors (RXRalpha, RXRbeta, and RXRgamma) are nuclear receptors that play key roles in multiple hormone-signaling pathways. Biochemical data indicate that, in the absence of ligand, RXR can exist as an inactive tetramer and that its dissociation, induced by ligand, is important for receptor activation. In this article we report the inactivated tetramer structures of the RXRalpha ligand-binding domain (LBD), either in the absence of or in the presence of a nonactivating ligand. These structures reveal that the RXR LBD tetramer forms a compact, disc-shaped complex, consisting of two symmetric dimers that are packed along helices 3 and 11. In each monomer, the AF-2 helix protrudes away from the core domain and spans into the coactivator binding site in the adjacent monomer of the symmetric dimer. In this configuration, the AF-2 helix physically excludes the binding of coactivators and suggests an autorepression mechanism that is mediated by the AF-2 helix within the tetramer. The RXR-tetramer interface is assembled from amino acids that are conserved across several closely related receptors, including the HNF4s and COUP transcription factors, and may therefore provide a model for understanding structure and regulation of this subfamily of nuclear receptors.

Reviews - 1g5y mentioned but not cited (1)

  1. The retinoid X receptors and their ligands. Dawson MI, Xia Z. Biochim. Biophys. Acta 1821 21-56 (2012)

Articles - 1g5y mentioned but not cited (15)

  1. Recognition of functional sites in protein structures. Shulman-Peleg A, Nussinov R, Wolfson HJ. J Mol Biol 339 607-633 (2004)
  2. Residues crucial for maintaining short paths in network communication mediate signaling in proteins. del Sol A, Fujihashi H, Amoros D, Nussinov R. Mol. Syst. Biol. 2 2006.0019 (2006)
  3. Nanoscale dewetting transition in protein complex folding. Hua L, Huang X, Liu P, Zhou R, Berne BJ. J Phys Chem B 111 9069-9077 (2007)
  4. Structural mechanism for signal transduction in RXR nuclear receptor heterodimers. Kojetin DJ, Matta-Camacho E, Hughes TS, Srinivasan S, Nwachukwu JC, Cavett V, Nowak J, Chalmers MJ, Marciano DP, Kamenecka TM, Shulman AI, Rance M, Griffin PR, Bruning JB, Nettles KW. Nat Commun 6 8013 (2015)
  5. Conformational changes in redox pairs of protein structures. Fan SW, George RA, Haworth NL, Feng LL, Liu JY, Wouters MA. Protein Sci 18 1745-1765 (2009)
  6. The "Phantom Effect" of the Rexinoid LG100754: structural and functional insights. Sato Y, Ramalanjaona N, Huet T, Potier N, Osz J, Antony P, Peluso-Iltis C, Poussin-Courmontagne P, Ennifar E, Mély Y, Dejaegere A, Moras D, Rochel N. PLoS ONE 5 e15119 (2010)
  7. The eccentric cleavage product of β-carotene, β-apo-13-carotenone, functions as an antagonist of RXRα. Eroglu A, Hruszkewycz DP, Curley RW, Harrison EH. Arch. Biochem. Biophys. 504 11-16 (2010)
  8. QM/MM refinement and analysis of protein bound retinoic acid. Li X, Fu Z, Merz KM. J Comput Chem 33 301-310 (2012)
  9. Survey of phosphorylation near drug binding sites in the Protein Data Bank (PDB) and their effects. Smith KP, Gifford KM, Waitzman JS, Rice SE. Proteins 83 25-36 (2015)
  10. Design, synthesis, and biological evaluation of indenoisoquinoline rexinoids with chemopreventive potential. Conda-Sheridan M, Park EJ, Beck DE, Reddy PV, Nguyen TX, Hu B, Chen L, White JJ, van Breemen RB, Pezzuto JM, Cushman M. J. Med. Chem. 56 2581-2605 (2013)
  11. Bayesian Modeling of Biomolecular Assemblies with Cryo-EM Maps. Habeck M. Front Mol Biosci 4 15 (2017)
  12. A multidisciplinary approach disclosing unexplored Aflatoxin B1 roles in severe impairment of vitamin D mechanisms of action. Persico M, Sessa R, Cesaro E, Dini I, Costanzo P, Ritieni A, Fattorusso C, Grosso M. Cell Biol Toxicol 39 1275-1295 (2023)
  13. A revisited version of the apo structure of the ligand-binding domain of the human nuclear receptor retinoic X receptor α. Eberhardt J, McEwen AG, Bourguet W, Moras D, Dejaegere A. Acta Crystallogr F Struct Biol Commun 75 98-104 (2019)
  14. Investigation of the Effects of Glabridin on the Proliferation, Apoptosis, and Migration of the Human Colon Cancer Cell Lines SW480 and SW620 and Its Mechanism Based on Reverse Virtual Screening and Proteomics. Li T, Li H, Xia W, Li M, Niu Y, Fu X. Oxid Med Cell Longev 2023 1117431 (2023)
  15. Percolation transition prescribes protein size-specific barrier to passive transport through the nuclear pore complex. Winogradoff D, Chou HY, Maffeo C, Aksimentiev A. Nat Commun 13 5138 (2022)


Reviews citing this publication (16)

  1. Peroxisome proliferator-activated receptor gamma and metabolic disease. Willson TM, Lambert MH, Kliewer SA. Annu. Rev. Biochem. 70 341-367 (2001)
  2. Nuclear receptor structure: implications for function. Bain DL, Heneghan AF, Connaghan-Jones KD, Miura MT. Annu. Rev. Physiol. 69 201-220 (2007)
  3. Between death and survival: retinoic acid in regulation of apoptosis. Noy N. Annu. Rev. Nutr. 30 201-217 (2010)
  4. Activation of nuclear receptors: a perspective from structural genomics. Li Y, Lambert MH, Xu HE. Structure 11 741-746 (2003)
  5. The PPAR-RXR transcriptional complex in the vasculature: energy in the balance. Plutzky J. Circ. Res. 108 1002-1016 (2011)
  6. Retinoic acid actions through mammalian nuclear receptors. Huang P, Chandra V, Rastinejad F. Chem. Rev. 114 233-254 (2014)
  7. Regulated assembly of transcription factors and control of transcription initiation. Beckett D. J. Mol. Biol. 314 335-352 (2001)
  8. Small molecule modulation of nuclear receptor conformational dynamics: implications for function and drug discovery. Kojetin DJ, Burris TP. Mol. Pharmacol. 83 1-8 (2013)
  9. A family-based approach reveals the function of residues in the nuclear receptor ligand-binding domain. Folkertsma S, van Noort P, Van Durme J, Joosten HJ, Bettler E, Fleuren W, Oliveira L, Horn F, de Vlieg J, Vriend G. J. Mol. Biol. 341 321-335 (2004)
  10. Different ligands-different receptor conformations: modeling of the hER alpha LBD in complex with agonists and antagonists. Egner U, Heinrich N, Ruff M, Gangloff M, Mueller-Fahrnow A, Wurtz JM. Med Res Rev 21 523-539 (2001)
  11. Regulation of the nongenomic actions of retinoid X receptor-α by targeting the coregulator-binding sites. Zhang XK, Su Y, Chen L, Chen F, Liu J, Zhou H. Acta Pharmacol. Sin. 36 102-112 (2015)
  12. Translation of a Tissue-Selective Rexinoid, UAB30, to the Clinic for Breast Cancer Prevention. Muccio DD, Atigadda VR, Brouillette WJ, Bland KI, Krontiras H, Grubbs CJ. Curr Top Med Chem 17 676-695 (2017)
  13. Targeting truncated RXRα for cancer therapy. Zhang X, Zhou H, Su Y. Acta Biochim. Biophys. Sin. (Shanghai) 48 49-59 (2016)
  14. A review of the molecular design and biological activities of RXR agonists. de Almeida NR, Conda-Sheridan M. Med Res Rev 39 1372-1397 (2019)
  15. Gene expression profiling discerns molecular pathways elicited by ligand signaling to enhance the specification of embryonic stem cells into skeletal muscle lineage. Dixon K, Chen J, Li Q. Cell Biosci 7 23 (2017)
  16. Overview of the structure-based non-genomic effects of the nuclear receptor RXRα. Chen L, Wu L, Zhu L, Zhao Y. Cell. Mol. Biol. Lett. 23 36 (2018)

Articles citing this publication (54)

  1. Inducible expression of the proallergic cytokine thymic stromal lymphopoietin in airway epithelial cells is controlled by NFkappaB. Lee HC, Ziegler SF. Proc. Natl. Acad. Sci. U.S.A. 104 914-919 (2007)
  2. Crystallographic identification and functional characterization of phospholipids as ligands for the orphan nuclear receptor steroidogenic factor-1. Li Y, Choi M, Cavey G, Daugherty J, Suino K, Kovach A, Bingham NC, Kliewer SA, Xu HE. Mol. Cell 17 491-502 (2005)
  3. Identification of COUP-TFII orphan nuclear receptor as a retinoic acid-activated receptor. Kruse SW, Suino-Powell K, Zhou XE, Kretschman JE, Reynolds R, Vonrhein C, Xu Y, Wang L, Tsai SY, Tsai MJ, Xu HE. PLoS Biol. 6 e227 (2008)
  4. Molecular recognition of agonist ligands by RXRs. Egea PF, Mitschler A, Moras D. Mol Endocrinol 16 987-997 (2002)
  5. Retinoid X receptor regulates Nur77/TR3-dependent apoptosis [corrected] by modulating its nuclear export and mitochondrial targeting. Cao X, Liu W, Lin F, Li H, Kolluri SK, Lin B, Han YH, Dawson MI, Zhang XK. Mol. Cell. Biol. 24 9705-9725 (2004)
  6. Determinants of CoRNR-dependent repression complex assembly on nuclear hormone receptors. Hu X, Li Y, Lazar MA. Mol. Cell. Biol. 21 1747-1758 (2001)
  7. Glucocorticoid receptor homodimers and glucocorticoid-mineralocorticoid receptor heterodimers form in the cytoplasm through alternative dimerization interfaces. Savory JG, Préfontaine GG, Lamprecht C, Liao M, Walther RF, Lefebvre YA, Haché RJ. Mol. Cell. Biol. 21 781-793 (2001)
  8. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR. Egea PF, Rochel N, Birck C, Vachette P, Timmins PA, Moras D. J. Mol. Biol. 307 557-576 (2001)
  9. Modular architecture of protein structures and allosteric communications: potential implications for signaling proteins and regulatory linkages. Del Sol A, Araúzo-Bravo MJ, Amoros D, Nussinov R. Genome Biol. 8 R92 (2007)
  10. Separation of retinoid X receptor homo- and heterodimerization functions. Vivat-Hannah V, Bourguet W, Gottardis M, Gronemeyer H. Mol. Cell. Biol. 23 7678-7688 (2003)
  11. The orphan nuclear receptor TR4 is a vitamin A-activated nuclear receptor. Zhou XE, Suino-Powell KM, Xu Y, Chan CW, Tanabe O, Kruse SW, Reynolds R, Engel JD, Xu HE. J. Biol. Chem. 286 2877-2885 (2011)
  12. Resveratrol inhibits MMP-9 expression by up-regulating PPAR alpha expression in an oxygen glucose deprivation-exposed neuron model. Cheng G, Zhang X, Gao D, Jiang X, Dong W. Neurosci. Lett. 451 105-108 (2009)
  13. Human PXR forms a tryptophan zipper-mediated homodimer. Noble SM, Carnahan VE, Moore LB, Luntz T, Wang H, Ittoop OR, Stimmel JB, Davis-Searles PR, Watkins RE, Wisely GB, LeCluyse E, Tripathy A, McDonnell DP, Redinbo MR. Biochemistry 45 8579-8589 (2006)
  14. Danthron functions as a retinoic X receptor antagonist by stabilizing tetramers of the receptor. Zhang H, Zhou R, Li L, Chen J, Chen L, Li C, Ding H, Yu L, Hu L, Jiang H, Shen X. J. Biol. Chem. 286 1868-1875 (2011)
  15. Interactions that determine the assembly of a retinoid X receptor/corepressor complex. Ghosh JC, Yang X, Zhang A, Lambert MH, Li H, Xu HE, Chen JD. Proc. Natl. Acad. Sci. U.S.A. 99 5842-5847 (2002)
  16. DNA-looping by RXR tetramers permits transcriptional regulation "at a distance". Yasmin R, Yeung KT, Chung RH, Gaczynska ME, Osmulski PA, Noy N. J. Mol. Biol. 343 327-338 (2004)
  17. Structural basis for retinoic X receptor repression on the tetramer. Zhang H, Chen L, Chen J, Jiang H, Shen X. J. Biol. Chem. 286 24593-24598 (2011)
  18. Contribution of retinoid X receptor signaling to the specification of skeletal muscle lineage. Le May M, Mach H, Lacroix N, Hou C, Chen J, Li Q. J. Biol. Chem. 286 26806-26812 (2011)
  19. Structural and functional insights into the ligand-binding domain of a nonduplicated retinoid X nuclear receptor from the invertebrate chordate amphioxus. Tocchini-Valentini GD, Rochel N, Escriva H, Germain P, Peluso-Iltis C, Paris M, Sanglier-Cianferani S, Van Dorsselaer A, Moras D, Laudet V. J Biol Chem 284 1938-1948 (2009)
  20. Crystal structure of a novel tetrameric complex of agonist-bound ligand-binding domain of Biomphalaria glabrata retinoid X receptor. de Groot A, de Rosny E, Juillan-Binard C, Ferrer JL, Laudet V, Pierce RJ, Pebay-Peyroula E, Fontecilla-Camps JC, Borel F. J. Mol. Biol. 354 841-853 (2005)
  21. Evolutionary trace-based peptides identify a novel asymmetric interaction that mediates oligomerization in nuclear receptors. Gu P, Morgan DH, Sattar M, Xu X, Wagner R, Raviscioni M, Lichtarge O, Cooney AJ. J Biol Chem 280 31818-31829 (2005)
  22. Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer. Korpal M, Puyang X, Jeremy Wu Z, Seiler R, Furman C, Oo HZ, Seiler M, Irwin S, Subramanian V, Julie Joshi J, Wang CK, Rimkunas V, Tortora D, Yang H, Kumar N, Kuznetsov G, Matijevic M, Chow J, Kumar P, Zou J, Feala J, Corson L, Henry R, Selvaraj A, Davis A, Bloudoff K, Douglas J, Kiss B, Roberts M, Fazli L, Black PC, Fekkes P, Smith PG, Warmuth M, Yu L, Hao MH, Larsen N, Daugaard M, Zhu P. Nat Commun 8 103 (2017)
  23. Structural insights into gene repression by the orphan nuclear receptor SHP. Zhi X, Zhou XE, He Y, Zechner C, Suino-Powell KM, Kliewer SA, Melcher K, Mangelsdorf DJ, Xu HE. Proc. Natl. Acad. Sci. U.S.A. 111 839-844 (2014)
  24. The effect of antagonists on the conformational exchange of the retinoid X receptor alpha ligand-binding domain. Lu J, Dawson MI, Hu QY, Xia Z, Dambacher JD, Ye M, Zhang XK, Li E. Magn Reson Chem 47 1071-1080 (2009)
  25. Defining the communication between agonist and coactivator binding in the retinoid X receptor α ligand binding domain. Boerma LJ, Xia G, Qui C, Cox BD, Chalmers MJ, Smith CD, Lobo-Ruppert S, Griffin PR, Muccio DD, Renfrow MB. J. Biol. Chem. 289 814-826 (2014)
  26. Dynamic correlation networks in human peroxisome proliferator-activated receptor-γ nuclear receptor protein. Fidelak J, Ferrer S, Oberlin M, Moras D, Dejaegere A, Stote RH. Eur. Biophys. J. 39 1503-1512 (2010)
  27. X-ray structures of the LXRalpha LBD in its homodimeric form and implications for heterodimer signaling. Fradera X, Vu D, Nimz O, Skene R, Hosfield D, Wynands R, Cooke AJ, Haunsø A, King A, Bennett DJ, McGuire R, Uitdehaag JC. J. Mol. Biol. 399 120-132 (2010)
  28. Sulindac-derived RXRα modulators inhibit cancer cell growth by binding to a novel site. Chen L, Wang ZG, Aleshin AE, Chen F, Chen J, Jiang F, Alitongbieke G, Zeng Z, Ma Y, Huang M, Zhou H, Cadwell G, Zheng JF, Huang PQ, Liddington RC, Zhang XK, Su Y. Chem. Biol. 21 596-607 (2014)
  29. Inhibition of mammary carcinoma cell growth by RXR is mediated by the receptor's oligomeric switch. Yasmin R, Kannan-Thulasiraman P, Kagechika H, Dawson MI, Noy N. J. Mol. Biol. 397 1121-1131 (2010)
  30. β-Apo-13-carotenone regulates retinoid X receptor transcriptional activity through tetramerization of the receptor. Sun J, Narayanasamy S, Curley RW, Harrison EH. J. Biol. Chem. 289 33118-33124 (2014)
  31. Transcriptional regulation of temperature-induced remodeling of muscle bioenergetics in goldfish. Bremer K, Monk CT, Gurd BJ, Moyes CD. Am. J. Physiol. Regul. Integr. Comp. Physiol. 303 R150-8 (2012)
  32. Critical role of charged residues in helix 7 of the ligand binding domain in Hepatocyte Nuclear Factor 4alpha dimerisation and transcriptional activity. Eeckhoute J, Oxombre B, Formstecher P, Lefebvre P, Laine B. Nucleic Acids Res. 31 6640-6650 (2003)
  33. Berberine binds RXRα to suppress β-catenin signaling in colon cancer cells. Ruan H, Zhan YY, Hou J, Xu B, Chen B, Tian Y, Wu D, Zhao Y, Zhang Y, Chen X, Mi P, Zhang L, Zhang S, Wang X, Cao H, Zhang W, Wang H, Li H, Su Y, Zhang XK, Hu T. Oncogene 36 6906-6918 (2017)
  34. Control of gene expression by modulated self-assembly. Vilar JM, Saiz L. Nucleic Acids Res. 39 6854-6863 (2011)
  35. Heme-binding to the nuclear receptor retinoid X receptor alpha (RXRalpha) leads to the inhibition of the transcriptional activity. Gotoh S, Ohgari Y, Nakamura T, Osumi T, Taketani S. Gene 423 207-214 (2008)
  36. Insights into interplay between rexinoid signaling and myogenic regulatory factor-associated chromatin state in myogenic differentiation. Hamed M, Khilji S, Dixon K, Blais A, Ioshikhes I, Chen J, Li Q. Nucleic Acids Res. 45 11236-11248 (2017)
  37. Local motifs involved in the canonical structure of the ligand-binding domain in the nuclear receptor superfamily. Tsuji M. J. Struct. Biol. 185 355-365 (2014)
  38. Retinoid X Receptor-selective Signaling in the Regulation of Akt/Protein Kinase B Isoform-specific Expression. AlSudais H, Aabed K, Nicola W, Dixon K, Chen J, Li Q. J. Biol. Chem. 291 3090-3099 (2016)
  39. Implication of retinoic acid receptor selective signaling in myogenic differentiation. Chen J, Li Q. Sci Rep 6 18856 (2016)
  40. Phosphorylation of PPARγ Affects the Collective Motions of the PPARγ-RXRα-DNA Complex. Lemkul JA, Lewis SN, Bassaganya-Riera J, Bevan DR. PLoS ONE 10 e0123984 (2015)
  41. Modulation of nongenomic activation of PI3K signalling by tetramerization of N-terminally-cleaved RXRα. Chen L, Aleshin AE, Alitongbieke G, Zhou Y, Zhang X, Ye X, Hu M, Ren G, Chen Z, Ma Y, Zhang D, Liu S, Gao W, Cai L, Wu L, Zeng Z, Jiang F, Liu J, Zhou H, Cadwell G, Liddington RC, Su Y, Zhang XK. Nat Commun 8 16066 (2017)
  42. Profiling of 3696 Nuclear Receptor-Coregulator Interactions: A Resource for Biological and Clinical Discovery. Broekema MF, Hollman DAA, Koppen A, van den Ham HJ, Melchers D, Pijnenburg D, Ruijtenbeek R, van Mil SWC, Houtman R, Kalkhoven E. Endocrinology 159 2397-2407 (2018)
  43. Purified promyelocytic leukemia coiled-coil aggregates as a tetramer displaying low alpha-helical content. Antolini F, Lo Bello M, Sette M. Protein Expr. Purif. 29 94-102 (2003)
  44. The multivalency of the glucocorticoid receptor ligand-binding domain explains its manifold physiological activities. Jiménez-Panizo A, Alegre-Martí A, Tettey TT, Fettweis G, Abella M, Antón R, Johnson TA, Kim S, Schiltz RL, Núñez-Barrios I, Font-Díaz J, Caelles C, Valledor AF, Pérez P, Rojas AM, Fernández-Recio J, Presman DM, Hager GL, Fuentes-Prior P, Estébanez-Perpiñá E. Nucleic Acids Res 50 13063-13082 (2022)
  45. Characterization of sea bass FSHβ 5' flanking region: transcriptional control by 17β-estradiol. Muriach B, Carrillo M, Zanuy S, Cerdá-Reverter JM. Fish Physiol. Biochem. 40 849-864 (2014)
  46. Crystal structure of the ligand-binding domain of the retinoid X receptor from the ascidian Polyandrocarpa misakiensis. Borel F, de Groot A, Juillan-Binard C, de Rosny E, Laudet V, Pebay-Peyroula E, Fontecilla-Camps JC, Ferrer JL. Proteins 74 538-542 (2009)
  47. Equilibrium unfolding of the retinoid X receptor ligand binding domain and characterization of an unfolding intermediate. Harder ME, Malencik DA, Yan X, Broderick D, Leid M, Anderson SR, Deinzer ML, Schimerlik MI. Biophys. Chem. 141 1-10 (2009)
  48. A structural signature motif enlightens the origin and diversification of nuclear receptors. Beinsteiner B, Markov GV, Erb S, Chebaro Y, McEwen AG, Cianférani S, Laudet V, Moras D, Billas IML. PLoS Genet 17 e1009492 (2021)
  49. Functional characterization of hepatocyte nuclear factor-4 alpha dimerization interface mutants. Aggelidou E, Iordanidou P, Demetriades C, Piltsi O, Hadzopoulou-Cladaras M. FEBS J. 273 1948-1958 (2006)
  50. Molecular basis of ligand-dependent Nurr1-RXRα activation. Yu X, Shang J, Kojetin DJ. Elife 12 e85039 (2023)
  51. Prospecting the therapeutic edge of a novel compound (B12) over berberine in the selective targeting of Retinoid X Receptor in colon cancer. Subair TI, Soremekun OS, Olotu FA, Soliman MES. J Mol Model 27 231 (2021)
  52. Dual conformation of the ligand induces the partial agonistic activity of retinoid X receptor α (RXRα). Miyashita Y, Numoto N, Arulmozhiraja S, Nakano S, Matsuo N, Shimizu K, Shibahara O, Fujihara M, Kakuta H, Ito S, Ikura T, Ito N, Tokiwa H. FEBS Lett. 593 242-250 (2019)
  53. The conformational dynamics of H2-H3n and S2-H6 in gating ligand entry into the buried binding cavity of vitamin D receptor. Tee WV, Ripen AM, Mohamad SB. Sci Rep 6 35937 (2016)
  54. The effect of S427F mutation on RXRα activity depends on its dimeric partner. Galdadas I, Bonis V, Vgenopoulou P, Papadourakis M, Kakoulidis P, Stergiou G, Cournia Z, Klinakis A. Chem Sci 12 14700-14710 (2021)


Related citations provided by authors (1)

  1. Asymmetry in the PPARalpha/RXRalpha Crystal Structure Reveals the Molecular Basis of Heterodimerization among Nuclear Receptors. Gampe Jr RT, Montana VG, Lambert MH, Miller AB, Bledsoe RK, Milburn MV, Kliewer SA, Willson TM, Xu HE Mol. Cell 5 545-555 (2000)

Quick links